Children's Cancer Web
Neuroblastoma On-line Researcher's Forum
Email Discussion ListMonthly List of Neuroblastoma PublicationsNeuroblastoma Genetics: Cancer Genetics WebNeuroblastoma Links: Children's Cancer Web
red ball Neuroblastoma Clinical Trials and Studies - Publications
This page is intended for physicians and research scientists.
Recent Publications about Clinical Trials & Studies
Related Resources
Back to NBL-PROF Home Page

Recent Publications

To view an abstract click on the title of the desired article. This will request Medline details from PubMed which is provided by the National Library of Medicine. After viewing the abstract use your browser's [Back] button to return to this page.

Langler A, et al.
Topotecan in the treatment of refractory neuroblastoma and other malignant tumors in childhood - a phase-II-study.
Klin Padiatr 2002 Jul-Aug;214(4):153-6    [Related articles]
Langler A, et al.
Topotecan in the treatment of refractory neuroblastoma and other malignant tumors in childhood - a phase-II-study.
Klin Padiatr 2002 Jul-Aug;214(4):153-6    [Related articles]
Kletzel M, et al.
Treatment of High-Risk Neuroblastoma With Triple-Tandem High-Dose Therapy and Stem-Cell Rescue: Results of the Chicago Pilot II Study.
J Clin Oncol 2002 May 1;20(9):2284-92    [Related articles]
Yanik GA, et al.
Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma.
J Clin Oncol 2002 Apr 15;20(8):2142-9    [Related articles]
Mugishima H, et al.
Phase I study of irinotecan in pediatric patients with malignant solid tumors.
J Pediatr Hematol Oncol 2002 Feb;24(2):94-100    [Related articles]
Geiger JD, et al.
Vaccination Of Pediatric Solid Tumor Patients with Tumor Lysate-pulsed Dendritic Cells Can Expand Specific T Cells and Mediate Tumor Regression.
Cancer Res 2001 Dec 1;61(23):8513-8519    [Related articles]
Castel V, et al.
Outcome of high-risk neuroblastoma using a dose intensity approach: Improvement in initial but not in long-term results.
Med Pediatr Oncol 2001 Dec;37(6):537-542    [Related articles]
Kushner BH, et al.
Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma.
J Clin Oncol 2001 Nov 15;19(22):4189-94    [Related articles]
Saylors RL 3rd, et al.
Cyclophosphamide Plus Topotecan in Children With Recurrent or Refractory Solid Tumors: A Pediatric Oncology Group Phase II Study.
J Clin Oncol 2001 Aug 1;19(15):3463-9    [Related articles]
Kushner BH, et al.
Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
J Clin Oncol 2001 Jul 15;19(14):3397-405    [Related articles]
Hug EB, et al.
Conformal proton radiation treatment for retroperitoneal neuroblastoma: introduction of a novel technique.
Med Pediatr Oncol 2001 Jul;37(1):36-41    [Related articles]
Tweddle DA, et al.
OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of age.
Med Pediatr Oncol 2001 Jan;36(1):239-42    [Related articles]
Rubie H, et al.
Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Societe Francaise d'Oncologie Pediatrique.
Med Pediatr Oncol 2001 Jan;36(1):247-50    [Related articles]
Cheung NK, et al.
N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.
Med Pediatr Oncol 2001 Jan;36(1):227-30    [Related articles]
Blaney S, et al.
A phase I study of irinotecan in pediatric patients: a pediatric oncology group study.
Clin Cancer Res 2001 Jan;7(1):32-7    [Related articles]
Park JR, et al.
Phase I topotecan preparative regimen for high-risk neuroblastoma, high-grade glioma, and refractory/recurrent pediatric solid tumors.
Med Pediatr Oncol 2000 Dec 1;35(6):719-723    [Related articles]
Ozkaynak MF, et al.
Phase I Study of Chimeric Human/Murine Anti-Ganglioside G(D2) Monoclonal Antibody (ch14.18) With Granulocyte-Macrophage Colony-Stimulating Factor in Children With Neuroblastoma Immediately After Hematopoietic S
J Clin Oncol 2000 Dec 15;18(24):4077-4085    [Related articles]
Kushner BH, et al.
Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors.
Med Pediatr Oncol 2000 Nov;35(5):468-74    [Related articles]
Kohler JA, et al.
A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy.
Br J Cancer 2000 Nov;83(9):1124-1127    [Related articles]
Berg SL, et al.
Phase II trial of pyrazoloacridine in children with solid tumors: a Pediatric Oncology Group phase II study.
J Pediatr Hematol Oncol 2000 Nov;22(6):506-9    [Related articles]
Minard V, et al.
Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French Society of Pediatric Oncology.
Br J Cancer 2000 Oct;83(8):973-979    [Related articles]
     MYCN Amplification
Fernandez MC, et al.
A Phase I dose escalation of combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with neuroblastoma.
Cancer. 2000 Jun;88(12):2838-2844.    [Related articles]
Valteau-Couanet D, et al.
Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma.
Bone Marrow Transplant. 2000 May;25(9):937-42.    [Related articles]
Maris JM, et al.
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.
J Clin Oncol. 2000 May;18(9):1888-99.    [Related articles]
     Chromosome 1p
Cotterill SJ, et al.
Clinical prognostic factors in 1277 patients with neuroblastoma: results of the European Neuroblastoma Study Group 'Survey' 1982-1992.
Eur J Cancer. 2000 May;36(7):901-8.    [Related articles]
Frappaz D, et al.
Metaiodobenzylguanidine assessment of metastatic neuroblastoma: observer dependency and chemosensitivity evaluation. The SFOP Group.
Med Pediatr Oncol. 2000 Apr;34(4):237-41.    [Related articles]
Frappaz D, et al.
LMCE3 Treatment Strategy: Results in 99 Consecutively Diagnosed Stage 4 Neuroblastomas in Children Older Than 1 Year at Diagnosis.
J Clin Oncol. 2000 Feb;18(3):468.    [Related articles]
Perez CA, et al.
Biologic Variables in the Outcome of Stages I and II Neuroblastoma Treated With Surgery as Primary Therapy: A Children's Cancer Group Study.
J Clin Oncol. 2000 Jan;18(1):18.    [Related articles]
Iwakawa M, et al.
Enhanced metastasis after local therapy in a murine model using C-1300 neuroblastoma.
J Pediatr Surg. 1999 Nov;34(11):1645-6.    [Related articles]
Matthay KK, et al.
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.
N Engl J Med. 1999 Oct 14;341(16):1165-73.    [Related articles]
Furman WL, et al.
Direct Translation of a Protracted Irinotecan Schedule From a Xenograft Model to a Phase I Trial in Children.
J Clin Oncol. 1999;17(6):1815.    [Related articles]
Castel V, et al.
Prospective evaluation of the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) in a multicentre setting.
Eur J Cancer. 1999; 35(4):606-11.    [Related articles]
Kawano Y, et al.
Marginal Benefit/Disadvantage of granulocyte colony-stimulating factor therapy after autologous blood stem cell transplantation in children: results of a prospective randomized trial.
Blood. 1998 Dec 1;92(11):4040-6.    [Related articles]
Shah S, et al.
Phase I therapy trials in children with cancer.
J Pediatr Hematol Oncol. 1998 Sep-Oct;20(5):431-8. Review.    [Related articles]
Cheung NK, et al.
Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age.
J Clin Oncol. 1998 Sep;16(9):3053-60.    [Related articles]
Pession A, et al.
Immunotherapy with low-dose recombinant interleukin 2 after high-dose chemotherapy and autologous stem cell transplantation in neuroblastoma.
Br J Cancer. 1998 Aug;78(4):528-33.    [Related articles]
Kaneko M, et al.
Stratification of treatment of stage 4 neuroblastoma patients based on N-myc amplification status. Study Group of Japan for Treatment of Advanced Neuroblastoma, Tokyo, Japan.
Med Pediatr Oncol 1998 Jul;31(1):1-7    [Related articles]
     MYCN Amplification
Yu AL, et al.
Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma.
J Clin Oncol. 1998 Jun; 16(6): 2169-2180.    [Related articles]
Rubie H, et al.
Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Societe Francaise d'Oncologie P
Br J Cancer 1998 Jun;77(12):2310-2317    [Related articles]
Michon JM, et al.
An open-label, multicentre, randomised phase 2 study of recombinant human granulocyte colony-stimulating factor (filgrastim) as an adjunct to combination chemotherapy in patients with metastatic neuroblastoma
Eur J Cancer. 1998 Jun;34(7):1063-9.    [Related articles]
Cheung NKV, et al.
3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study.
Int J Oncol. 1998 Jun; 12(6): 1299-1306.    [Related articles]
Bruggers CS, et al.
Efficacy of surveillance radiographic imaging in detecting progressive disease in children with advanced stage neuroblastoma.
J Pediatr Hematol Oncol. 1998 Mar-Apr;20(2):104-7.    [Related articles]
Seeger RC, et al.
A Phase I study of human gamma interferon gene-transduced tumor cells in patients with neuroblastoma.
Hum Gene Ther. 1998 Feb 10;9(3):379-90.    [Related articles]
Matthay KK, et al.
Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma.
J Clin Oncol. 1998 Jan;16(1):229-36.    [Related articles]
Kletzel M, et al.
Thiotepa and cyclophosphamide with stem cell rescue for consolidation therapy for children with high-risk neuroblastoma: a phase I/II study of the Pediatric Blood and Marrow Transplant Consortium.
J Pediatr Hematol Oncol. 1998 Jan-Feb;20(1):49-54.    [Related articles]
Coze C, et al.
NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology.
J Clin Oncol. 1997 Dec;15(12):3433-40.    [Related articles]
Cohn SL, et al.
Treatment of poor-risk neuroblastoma patients with high-dose chemotherapy and autologous peripheral stem cell rescue.
Bone Marrow Transplant. 1997 Oct;20(7):543-51.    [Related articles]
Frost JD, et al.
A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma: a report of the Children's Cancer Group.
Cancer. 1997 Jul 15;80(2):317-33.    [Related articles]
Matthay KK, et al. Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
J Clin Oncol 1998 Apr;16(4):1256-64
     MYCN Amplification
Klingebiel T, et al.
Treatment of neuroblastoma stage 4 with 131I-meta-iodo-benzylguanidine, high-dose chemotherapy and immunotherapy. A pilot study.
Eur J Cancer. 1998 Aug;34(9):1398-402.    [Related articles]

Related Resources

Search PUBMED for "TITLE: neuroblastoma AND clinical trials"
(National Library of Medicine, USA)
Web Resources about Neuroblastoma (Children's Cancer Web)
Web Resources about Clinical Trials (Guide to Internet Resources for Cancer)

Back to NBL-PROF Home Page

First created: 10/01/99
Last Modified: 20/07/2003